Thermo Fisher Scientific (TMO) Operating Expenses (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Operating Expenses for 18 consecutive years, with $9.1 billion the latest figure, recorded in Q1 2026.

• Operating Expenses for Q1 2026 came in at $9.1 billion, up 5.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $37.3 billion (up 5.06% YoY), and the FY2025 annual result was $36.8 billion, up 3.57% from the prior year.
• Operating Expenses was $9.1 billion for Q1 2026 at Thermo Fisher Scientific, down from $10.0 billion in the prior quarter.
• Over five years, Operating Expenses peaked at $10.0 billion in Q4 2025 and troughed at $8.6 billion in Q1 2025.
• Average Operating Expenses over 5 years is $9.1 billion, with a median of $9.0 billion recorded in 2025.
• Year-over-year, Operating Expenses surged 31.21% in 2022 and fell 5.81% in 2023.
• Over 5 years, Operating Expenses stood at $9.6 billion in 2022, then declined by 5.81% to $9.0 billion in 2023, then gained by 3.84% to $9.4 billion in 2024, then advanced by 6.19% to $10.0 billion in 2025, then slipped by 8.21% to $9.1 billion in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $9.1 billion in Q1 2026, $10.0 billion in Q4 2025, and $9.2 billion in Q3 2025.